Pacific Biosciences
PACB
#6500
Rank
NZ$1.02 B
Marketcap
$3.48
Share price
2.07%
Change (1 day)
-78.22%
Change (1 year)

Pacific Biosciences (PACB) - Cash on Hand

Cash on Hand as of September 2024 : NZ$0.83 Billion

According to Pacific Biosciences 's latest financial reports the company has NZ$0.83 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Pacific Biosciences - Cash on Hand chart (from 2009 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$0.99 B-17.92%
2022-12-31NZ$1.21 B-20.44%
2021-12-31NZ$1.52 B246.05%
2020-12-31NZ$0.44 B506.08%
2019-12-31NZ$72.9 M-52.22%
2018-12-31NZ$0.15 B72.37%
2017-12-31NZ$88.52 M-14.81%
2016-12-31NZ$0.10 B-13.55%
2015-12-31NZ$0.12 B-7.07%
2014-12-31NZ$0.12 B-5.54%
2013-12-31NZ$0.13 B12%
2012-12-31NZ$0.12 B-46.22%
2011-12-31NZ$0.22 B-38.17%
2010-12-31NZ$0.36 B187.99%
2009-12-31NZ$0.12 B-30.13%
2008-12-31NZ$0.18 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$1.66 B 99.30%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.17 B-79.39%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$28.22 B 3,286.63%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$11.75 B 1,310.39%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$4.35 B 422.37%๐Ÿ‡บ๐Ÿ‡ธ USA